Aquestive Therapeutics Earning Date (AQST)

USA |NASDAQ |USD

AQST Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 1, 2022 Jun 2022 $-0.42 $-0.32 $-0.33
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 1, 2022 Jun 2022 $11.30M $-1.86B $15.35M

Aquestive Therapeutics's next earnings date is Monday, Aug 1, 2022 for the fiscal quarter ending Jun 2022.

AQST Earnings Date & History Chart

AQST Earnings & Revenue Forecast

AQST Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 5 $-0.42 $-0.49 $-0.31
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $-1.63 $-1.98 $-1.34
Dec 2023 3 $-0.87 $-1.58 $-0.36

AQST Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 1 / 0 $-0.42 $-0.39 $-0.39
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 1 / 0 $-1.65 $-1.53 $-1.53
Dec 2023 1 / 0 $-0.89 $0.47 $0.47

AQST Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 5 $11.30M $10.50M $13.09M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $48.02M $42.90M $55.76M
Dec 2023 4 $90.20M $73.20M $109.60M

AQST Earnings Date & Revenue History

AQST Earnings History

|
Show More
Show More

AQST Revenue History

|
Show More
Show More

Aquestive Therapeutics Next Earnings Date & Report

AQST Next Earnings Date & Report Preview: Jun 2022 (FQ)

AQST's next earnings date is Monday, Aug 1, 2022 for the fiscal quarter ending Jun 30, 2022.

According to analysts, the average EPS estimation for Aquestive Therapeutics's next quarterly earnings is $-0.42, with a low EPS estimation of $-0.49, and a high estimation of $-0.31.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $-0.42, the last 2 month trend is $-0.39, and the 3 month trend is $-0.39.

Based on analysts, the average revenue estimation is $11.30M, with a low revenue estimation of $10.50M, and a high estimation of $13.09M.

Aquestive Therapeutics Previous Earnings Dates & Reports

AQST Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Aquestive Therapeutics's previous earnings date was May 3, 2022 for its fiscal quarter ended Mar 31, 2022.

AQST's earnings per share (EPS) was $-0.32, beating the consensus analysts forecast of $-0.41 by 21.95%.

The EPS was higher than the previous fiscal quarter (Dec 2021) by -15.79%, and higher than the same period a year before (Mar 2021) by -21.95%.

Revenues were $-1.86B.

The company reported a net income of $-13.22B.

AQST ended the quarter with $2.64M in total debt, a decrease of -29.59% compared to the previous quarter, and a decrease of -93.64% compared to the same quarter a year before.

AQST Previous Earnings Date & Report Recap: Dec 2021 (FY)

Aquestive Therapeutics's previous annual earnings date was Mar 8, 2022 for its fiscal year ended Dec 31, 2021.

AQST's earnings per share (EPS) was $-1.49, beating the consensus analysts forecast of $-1.59 by -6.29% , and higher than the previous year's EPS (Dec 2020) by -10.24%.

Revenues were $50.83M, better than the forecast of $49.10M by 3.53%, and up by 10.87% from previous year's revenue.

The company reported a net income of $-70.54M.

Aquestive Therapeutics reported a free cash flow of $-32.98M for its fiscal year, compared to $-45.98M a year ago.

The company ended the fiscal year with $899.00K in total debt, a decrease of -97.78% compared to the previous year.